Biobanks, personalised medicine, and artificial intelligence: legal and ethical perspectives
Identification
- Public canonical key
- doi:10.12681/bioeth.45067
- Authors
- Karl-Philippe Bretel
- Reported year
- 2026
- Reported language
- en
- Source type
- article
- First detected
- 2026-11-09T19:04:47.723659+00:00
- Last metadata observation
- 2026-11-09T19:04:47.723659+00:00
- Last HTTP verification
- Not checked
Institutions reported by the source
Université Paris 8
Reported affiliation countries
FR
Documentary abstract — original language
Biobanks and personalised medicine have become central pillars of contemporary biomedical research, reflecting a broader ambition to move towαrds more precise, preventive, and patient-centred healthcare models. By enabling the large-scale collection and long-term storage of biological samples and associated data, biobanks provide the foundational infrastructure required for advances in genomics, precision therapies, and data-driven medical innovation. The integration of artificial intelligence (AI) into this ecosystem further amplifies their potential, while simultaneously raising complex legal and ethical challenges. This article examines the evolving role of biobanks in personalised medicine through a legal and ethical lens, with particular attention to the regulatory fragmentation that characterises this field at the international level. Despite the existence of accreditation standards and ethical declarations developed by international organisations, biobanks remain primarily governed by national legal frameworks. This lack of harmonisation results in significant differences between jurisdictions regarding consent models, data protection safeguards, international data sharing, and the involvement of private actors. Through a comparative analysis of selected countries, including France, Sweden, and the United States, the article highlights how divergent regulatory approaches shape both research practices and the protection of individual rights. Ultimately, this study argues that the sustainable development of biobanks and AI enabled personalised medicine depends on robust governance mechanisms, transparent consent practices, and strong ethical oversight. Ethics committees, legal safeguards, and international cooperation remain essential to ensuring that innovation in this field benefits society as a whole without undermining individual rights or social equity.
Identifiers
- OPENALEX
- W7147113768
- DOI
- 10.12681/bioeth.45067
Documentary context
- Documentary family
- Scholarship
- Source-reported types
- article
- Natural entities mentioned
- Ecosystem
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1 · Record 2
Documentary field provenance
Source-backed values and values with unresolved provenance are kept separately. Bibliographic provenance validates no legal claim.
- Title
- Documentary source reported
- Publication
- Documentary source reported
- Authors
- Documentary source reported
- Document type
- Documentary source reported
- Jurisdiction
- Not recorded
- Court
- Not recorded
- Issuing authority
- Not recorded
- Publisher
- Not recorded
- DOI
- Documentary source reported
- ISBN
- Not recorded
- Official identifier
- Not recorded
- Source URL
- Documentary source reported
- Source-reported status
- Not recorded
- Amendment / repeal
- Not recorded
Cite this reference
Karl-Philippe Bretel. Biobanks, personalised medicine, and artificial intelligence: legal and ethical perspectives. 2026. https://doi.org/10.12681/bioeth.45067
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- Karl-Philippe Bretel. (2026). Biobanks, personalised medicine, and artificial intelligence: legal and ethical perspectives. https://doi.org/10.12681/bioeth.45067
- Chicago
- Karl-Philippe Bretel. Biobanks, personalised medicine, and artificial intelligence: legal and ethical perspectives. 2026. https://doi.org/10.12681/bioeth.45067
- ISO 690
- Karl-Philippe Bretel. Biobanks, personalised medicine, and artificial intelligence: legal and ethical perspectives. 2026. https://doi.org/10.12681/bioeth.45067
UDTR Global Rights of Nature Legal Library. Biobanks, personalised medicine, and artificial intelligence: legal and ethical perspectives. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-b30570a3b63bd7b241b0cf9e23324e2d/ · Last HTTP verification: not performed
Field provenance and record version
Version e70585be3983e6e9 · udtr-reference-1.1.2
- Title
- OpenAlex · source · 2026-11-09T19:04:47.723659+00:00
- Authors
- OpenAlex · source · 2026-11-09T19:04:47.723659+00:00
- Year
- OpenAlex · source · 2026-11-09T19:04:47.723659+00:00
- Identifiers
- OpenAlex · source · 2026-11-09T19:04:47.723659+00:00
- Source URL
- OpenAlex · source · 2026-11-09T19:04:47.723659+00:00
History tracks record metadata and does not certify the state of the law.
ec3325088459da50 · 2026-11-09T19:04:47.723659+00:00
b691353ffdb762cf · 2026-11-09T19:04:47.723659+00:00
342bc4a1145835ff · 2026-11-09T19:04:47.723659+00:00
e70585be3983e6e9 · 2026-11-09T19:04:47.723659+00:00
Research dossiers and documentary relations
Source roles
Discovery source · https://doi.org/10.12681/bioeth.45067
Discovery source · https://openalex.org/W7147113768
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.